Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for Active Alveolitis in Systemic Sclerosis
NCT00512902Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in systemic sclerosis (SSc), sponsored by University of California, Los Angeles. Started Aug 2007; status: completed.
02
Drugs
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00512902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512902.